Literature DB >> 1890487

Non-Hodgkin's lymphoma among Vietnam veterans.

N A Dalager1, H K Kang, V L Burt, L Weatherbee.   

Abstract

In light of findings suggesting an increase in the risk for non-Hodgkin's lymphoma among men exposed to phenoxyherbicides and concerns among veterans over Agent Orange exposure, a hospital-based case-control study was undertaken to examine the association between military service in Vietnam and non-Hodgkin's lymphoma. The cases consisted of 201 Vietnam-era veteran patients who were treated in one of 172 Department of Veterans Affairs hospitals from 1969 through 1985 with a diagnosis of non-Hodgkin's lymphoma. 358 Vietnam-era veteran patients with a diagnosis other than malignant lymphoma served as a comparison group. Military service information was obtained from a review of the veteran's military personnel records. Service in Vietnam did not increase the risk of non-Hodgkin's lymphoma either in general (branch adjusted odds ratio = 1.03, 95% confidence interval = 0.70-1.50) or with increased latency period as defined as the duration in years from first service in Vietnam to hospital discharge. Surrogate measures of potential Agent Orange exposure such as service in a specific military branch, in a certain region within Vietnam, or in a combat role as determined by military occupational speciality were not associated with any increased risk of non-Hodgkin's lymphoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1890487

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  3 in total

Review 1.  TCDD biomonitoring and exposure to Agent Orange: still the gold standard.

Authors:  Alvin L Young
Journal:  Environ Sci Pollut Res Int       Date:  2004       Impact factor: 4.223

Review 2.  Cancer in phenoxy herbicide manufacturing workers in Denmark, 1947-87--an update.

Authors:  E Lynge
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

Review 3.  Phenoxy herbicides, soft-tissue sarcoma and non-Hodgkin lymphoma: a systematic review of evidence from cohort and case-control studies.

Authors:  Nimeshi Jayakody; E Clare Harris; David Coggon
Journal:  Br Med Bull       Date:  2015-03-19       Impact factor: 4.291

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.